BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27981350)

  • 1. The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma.
    Xie S; Wang X; Ren J; Liu W
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2071-2078. PubMed ID: 27981350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiopathogenesis of cholesteatoma.
    Olszewska E; Wagner M; Bernal-Sprekelsen M; Ebmeyer J; Dazert S; Hildmann H; Sudhoff H
    Eur Arch Otorhinolaryngol; 2004 Jan; 261(1):6-24. PubMed ID: 12835944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between individual ossicular status and conductive hearing loss in cholesteatoma.
    Martins O; Victor J; Selesnick S
    Otol Neurotol; 2012 Apr; 33(3):387-92. PubMed ID: 22410730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of PTHrP and RANKL in acquired middle ear cholesteatoma epithelium.
    Xie S; Pan Z; Yin T; Ren J; Liu W
    Acta Otolaryngol; 2020 May; 140(5):351-355. PubMed ID: 32108533
    [No Abstract]   [Full Text] [Related]  

  • 5. MDCT of the temporal bone and audiological findings of pediatric acquired cholesteatoma.
    Tanrivermis Sayit A; Saglam D; Gunbey HP; Tastan M; Celenk C
    Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):3959-3964. PubMed ID: 28828536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone resorption in chronic otitis media: the role of the osteoclast.
    Jung JY; Chole RA
    ORL J Otorhinolaryngol Relat Spec; 2002; 64(2):95-107. PubMed ID: 12021500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of cytokines in cholesteatoma tissue.
    Marenda SA; Aufdemorte TB
    Otolaryngol Head Neck Surg; 1995 Mar; 112(3):359-68. PubMed ID: 7532849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is reuse of autologous ear ossicles in cholesteatoma or chronic suppurative otitis media justified?].
    Peng JC; Hoppe F
    Laryngorhinootologie; 1994 Jul; 73(7):375-80. PubMed ID: 7916783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Computed tomography (CT) of the temporal bone in diagnosis of acquired cholesteatoma of the middle ear].
    Zelikovich EI
    Vestn Otorinolaringol; 2004; (5):28-32. PubMed ID: 15602483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible participation of acidic pH in bone resorption in middle ear cholesteatoma.
    Nguyen KH; Suzuki H; Ohbuchi T; Wakasugi T; Koizumi H; Hashida K; Baba R; Morimoto H; Doi Y
    Laryngoscope; 2014 Jan; 124(1):245-50. PubMed ID: 24122656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aural cholesteatoma: role of tumor necrosis factor-alpha in bone destruction.
    Sastry KV; Sharma SC; Mann SB; Ganguly NK; Panda NK
    Am J Otol; 1999 Mar; 20(2):158-61. PubMed ID: 10100515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ear ossicle transplants for reconstruction of sound transmission in the middle ear. A histologic long-term study].
    Hildmann H; Karger B; Steinbach E
    Laryngorhinootologie; 1992 Jan; 71(1):5-10. PubMed ID: 1543522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological Changes of the Middle Ear Ossicles Harvested during Cholesteatoma Surgery.
    Školoudík L; Šimáková E; Kalfeřt D; Chrobok V
    Acta Medica (Hradec Kralove); 2015; 58(4):119-22. PubMed ID: 26960823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of osteoclasts in middle ear cholesteatoma: a study of undecalcified bone sections.
    Koizumi H; Suzuki H; Kawaguchi R; Hashida K; Hohchi N; Ohkubo JI; Tabata T; Kitamura T
    Acta Otolaryngol; 2017 Feb; 137(2):127-130. PubMed ID: 27575923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive intratemporal cholesteatoma: surgical strategy.
    Grayeli AB; Mosnier I; El Garem H; Bouccara D; Sterkers O
    Am J Otol; 2000 Nov; 21(6):774-81. PubMed ID: 11078062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical analysis of secondary acquired cholesteatoma.
    Yamamoto K; Yaguchi Y; Kojima H
    Am J Otolaryngol; 2014; 35(5):589-93. PubMed ID: 25069388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of patients with labyrinthine fistulae caused by middle ear cholesteatoma.
    Yang JM; Chi FL; Han Z; Huang YB; Li YK
    Chin Med J (Engl); 2013; 126(11):2116-9. PubMed ID: 23769568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reply to the Letter to the Editor regarding "Etiopathogenesis of bone resorption in acquired middle ear cholesteatoma".
    Xie S; Liu W; Ren J
    Eur Arch Otorhinolaryngol; 2017 Dec; 274(12):4253. PubMed ID: 28791463
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of labyrinthine fistula: hearing preservation versus prevention of residual disease.
    Geerse S; de Wolf MJF; Ebbens FA; van Spronsen E
    Eur Arch Otorhinolaryngol; 2017 Oct; 274(10):3605-3612. PubMed ID: 28799140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ossicular Chain Lesions in Tympanic Perforations and Chronic Otitis Media without Cholesteatoma.
    Albera R; Dagna F; Filippini C; Albera A; Canale A
    J Int Adv Otol; 2015 Aug; 11(2):143-6. PubMed ID: 26381005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.